v3.26.1
EARNINGS PER COMMON SHARE
 6 Months Ended
Jun. 30, 2026
Earnings Per Share [Abstract]  
EARNINGS PER COMMON SHARE EARNINGS PER COMMON SHARE
The following table illustrates the computation of basic and diluted earnings per share (in thousands, except share and per share amounts):
Three Months Ended June 30,Six Months Ended June 30,
2026202520262025
Numerator
Net (loss) income attributable to Sabra Health Care REIT, Inc.$(25,202)$65,542 $15,678 $105,846 
Denominator
Basic weighted average common shares and common equivalents252,268,939 237,976,314 252,202,390 237,933,910 
Dilutive restricted stock units— 2,755,911 2,524,248 2,671,820 
Dilutive forward equity sale agreements— 197,641 1,028,859 105,657 
Diluted weighted average common shares252,268,939 240,929,866 255,755,497 240,711,387 
Net (loss) income attributable to Sabra Health Care REIT, Inc., per:
Basic common share$(0.10)$0.28 $0.06 $0.44 
Diluted common share$(0.10)$0.27 $0.06 $0.44 
During the three and six months ended June 30, 2026, approximately 1.1 million and 66,000 shares, respectively, related to forward equity sale agreements were not included in computing diluted earnings per share because they were considered anti-dilutive. During the three months ended June 30, 2026, approximately 2.6 million restricted stock units were not included in computing diluted earnings per share because they were considered anti-dilutive. During the three and six months ended June 30, 2025, approximately 100 and 400 restricted stock units, respectively, and 22,000 and 40,000 shares, respectively, related to forward equity sale agreements were not included in computing diluted earnings per share because they were considered anti-dilutive.